Drive 6 phase II/III clinical studies across Russia and 1 study across Russia and Ukraine from start-up to long-term follow-up. Liaise with 23 local/international vendors (e.g. insurance/customs, IP/supplies, data entry, clinical trial management systems). Oversee a total of direct 19 reports. Clinical Study Expansion/Set-Up • Achieved a 4-fold increase in subject enrollment in 14 months to 75 subjects from 19 in secondary osteoporosis study, despite 5 subsequent increases of country subject enrollment commitment o Secured >30% of country enrollment & 6 top-enrollers when selected 14 new investigative sites for 2 psoriatic arthritis & 1 pediatric hematology study • Initiated 30+ investigative sites, led enrollment of 250+ subjects & oversaw training of 15 clinical research associates o Performed 28 in-person site co-monitoring visits, 400+ report reviews and 50+ sites feasibility assessments, maintained 100% report review compliance rate. • Increased site management oversight to 19 sites/117 subjects from initial identification, initiation and set-up of 14 sites/84 subjects for 2 psoriatic arthritic studies. o Voluntarily added management oversight of 5 sites/33 subjects after cancellation of site participation in Germany/U.S. in 2 psoriatic arthritic studies o Voluntarily committed to 35% increase of country subject enrollment commitment in pediatric immune thrombocytopenia study • Prepared 4 initial clinical trial applications approved by regulatory authorities and ethics committees across Russia and Ukraine • Became 1st of 18 participating countries to obtain approval (75 days) for pediatric immune thrombocytopenia study Clinical Study Management • Achieved at least 90% research subject retention rate across all studies • Increased to 120% from 60% country subject enrollment rate in prostate cancer study, o Met at least 100% of country enrollment target in all studies o Spiked to 80% from 14% timely completion rate of case report forms in prostate cancer study • Prepared 50+ approved clinical trial submissions/notifications to regulatory agencies & institution review boards (IRBs) • Maintained 100% compliance with project milestones for 2 psoriatic arthritis & 1 pediatric hematology study across: feasibility, regulatory submission, site evaluation, contracting to 1st subject enrollment o Improved to >90% overall data entry and query resolution rate compliance through spearheading institution of data entry improvement plans at underperforming investigative sites • Generated 63 country/29 site-specific versions of informed consent forms for 5 studies • Obtained 20+ investigational product import licenses & biological samples export licenses for 5 studies

Drove 5 clinical studies in: liver cancer, breast cancer, Alzheimer’s, schizophrenia, pediatric psoriasis across 15 investigative sites and 120 enrolled subjects. Performed site/country feasibility in all studies with 75 sites approached. Prepared submissions to institution review boards (IRBs). Worked with 16 local/international vendors. Developed/revised country SOP and WI on Regulatory/Ethics Submission and subject’s referral process. Clinical Research Management/SME Served as both CRA and study lead in 3 studies (psoriasis, breast cancer, Alzheimer’s); supervised Quintiles (CRO) in breast cancer study Grew by 40% subject recruitment rate for 170 Alzheimer’s study subjects through increase of potential subject referrals from city clinics/hospitals through initiation of patient referral program Negotiated ~80% of sites in 2 studies to base budget, freeing up funds for investment in other trials

Performed monitoring and site management, IRB/EC submissions and coordination of 5 clinical trial studies

Administrative support in 4 clinical studies.

Reception of patients, bill settlement, coordination of patient appointments.

Administrative support to Director General